GSK reaches out to help seriously ill children at LRH
CSR PROJECT: Children admitted to Ward 4 of the Lady Ridgeway
Hospital have access to improved care following the donation of a
well-equipped High Dependency Unit (HDU) to the ward by GlaxoSmithKline
Pharmaceuticals (GSK).
The HDU which can accommodate four seriously ill children and one
premature infant, has been equipped with multi parameter monitors,
infusion pumps, syringe pumps and pulse oxymeters, enabling it to offer
most of the care provided at an Intensive Care Unit (ICU) within the
ward.
GSK has also undertaken to install air-conditioning at the unit in
the next phase of the project, which will cost Rs. 4 million on
completion. GSK Managing Director Stuart Chapman said: "We were happy to
accommodate this request and provide a much needed facility that would
ease the pressure on the hospital's ICU and enable the doctors and
nursing staff of Ward 4 to monitor and treat the seriously ill children.
This initiative is perfectly in line with GSK's global mission to
improve the quality of human life by enabling people to feel better and
live longer."
The project involved the replacement of the old wooden partitions
with aluminium, the installation of new grills on the windows, new light
fittings and fans, the installation of new railings and screens,
painting of the walls and ceiling, provision of new furniture and
curtains, and the supply of medical equipment.
The 86-bed Ward 4 is one of six medical wards at the Lady Ridgeway
Hospital, one of the largest paediatric hospitals in the world. Dr.
Padmakanthi Wijesuriya, Consultant Paediatrician of Ward 4 said the new
High Dependency Unit is fully equipped to treat very sick children who
need intensive care and monitoring, and only those in need of a
ventilator would now have to be transferred to the hospital's ICU.
|